1-20 of 24
Giancarlo Agnelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Time Courses of Recurrent Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer

Katherine J. Creeper, Alexander T Cohen, Raza Alikhan, Jean M. M Connors, Menno V Huisman, Andres Munoz, Giorgio Vescovo, Rupert Bauersachs, Giancarlo Agnelli, Cecilia Becattini
Journal: Blood
Blood (2022) 140 (Supplement 1): 8515–8517.
https://doi.org/10.1182/blood-2022-168115
Published: 2022
Journal Articles

Acute Pulmonary Embolism and Cancer: Clinical Features, Management and Short-Term Course. Findings from the COPE Study

Cecilia Becattini, Ludovica Anna Cimini, Giorgio Bassanelli, Aldo P Maggioni, Fulvio Pomero, Ilaria Lobascio, Daniela P Pomata, Maria P Ruggeri, Beniamino Zalunardo, Anna Novelli, Giancarlo Agnelli, Lucio Gonzini, Michele M Gulizia
Journal: Blood
Blood (2022) 140 (Supplement 1): 5680–5681.
https://doi.org/10.1182/blood-2022-169152
Published: 2022
Journal Articles

Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer

Clinical Trials & Observations
Cecilia Becattini, Ugo Pace, Felice Pirozzi, Annibale Donini, Giampiero Avruscio, Fabio Rondelli, Michela Boncompagni, Damiano Chiari, Marco De Prizio, Adriana Visonà, Raffaele De Luca, Francesco Guerra, Andrea Muratore, Giuseppe Portale, Marco Milone, Giampaolo Castagnoli, Marc Righini, Jacopo Martellucci, Roberto Persiani, Stefania Frasson, Francesco Dentali, Paolo Delrio, Mauro Campanini, Gualberto Gussoni, Maria Cristina Vedovati, Giancarlo Agnelli
Journal: Blood
Blood (2022) 140 (8): 900–908.
https://doi.org/10.1182/blood.2022015796
Published: 2022
Includes: Supplemental data
Journal Articles

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis after Laparoscopic Surgery for Colorectal Cancer. the PRO-LAPS II Study

Cecilia Becattini, Ugo Pace, Felice Pirozzi, Giampiero Avruscio, Annibale Donini, Fabio Rondelli, Adriana Visonà, Michela Boncompagni, Marco De Prizio, Damiano Chiari, Andrea Muratore, Francesco Guerra, Raffaele De Luca, Giuseppe Portale, Marco Milone, Marc Righini, Giampaolo Castagnoli, Roberto Persiani, Jacopo Martellucci, Stefania Frasson, Francesco Dentali, Paolo Delrio, Antonio Sciuto, Gualberto Gussoni, Giancarlo Agnelli
Journal: Blood
Blood (2021) 138 (Supplement 1): 1064.
https://doi.org/10.1182/blood-2021-149093
Published: 2021
Journal Articles

Contemporary Clinical Management and Course of ACUTE Pulmonary Embolism: The COPE Study

Cecilia Becattini, Giancarlo Agnelli, Aldo P Maggioni, Francesco Dentali, Andrea Fabbri, Iolanda Enea, Fulvio Pomero, Maria P Ruggeri, Andrea Di Lenarda, Ludovica A Cimini, Giuseppe Pepe, Susanna Cozzio, Michele Diamanti, Simone Vanni, Donata Lucci, Michele M Gulizia
Journal: Blood
Blood (2021) 138 (Supplement 1): 3230.
https://doi.org/10.1182/blood-2021-149144
Published: 2021
Journal Articles

Acute treatment of venous thromboembolism

Clinical Trials & Observations
Cecilia Becattini, Giancarlo Agnelli
Journal: Blood
Blood (2020) 135 (5): 305–316.
https://doi.org/10.1182/blood.2019001881
Published: 2020
Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Faizan Khan, BSc, Alvi Rahman, MSc, Marc Carrier, MD MSc, Clive Kearon, MB, PhD, Jeffrey I. Weitz, MD, Sam Schulman, MD PhD FRCPC, Francis Couturaud, MD PhD, Sabine Eichinger, MD, Paul Alexander Kyrle, MD, Cecilia Becattini, MD PhD, Giancarlo Agnelli, MD, Timothy Brighton, MD, Anthonie WA. Lensing, MD PhD, Martin H. Prins, MD PhD, Elham Sabri, MSc, Brian Hutton, PhD, Laurent Pinede, MD PhD, Mary Cushman, MD MSc, Gualtiero Palareti, MD, George Wells, PhD, Paolo Prandoni, MD PhD, Harry R. Büller, MD PhD, Marc A. Rodger, MD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 2527.
https://doi.org/10.1182/blood-2018-99-113589
Published: 2018
Journal Articles

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Davendra P. S. Sohal, MD MPH, Nicole M. Kuderer, MD, Frances A. Shepherd, MD FRCPC, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Gary H. Lyman, MD MPH, Alok A. Khorana, MD
Journal: Blood
Blood (2016) 128 (22): 1422.
https://doi.org/10.1182/blood.V128.22.1422.1422
Published: 2016
Journal Articles

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Nicole M. Kuderer, MD, Marek S. Poniewierski, MD MS, MS, Eva Culakova, PhD MS, Gary H. Lyman, MD MPH, Alok A. Khorana, MD, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Frances A. Shepherd, MD FRCPC
Journal: Blood
Blood (2016) 128 (22): 3590.
https://doi.org/10.1182/blood.V128.22.3590.3590
Published: 2016
Journal Articles

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Alexander Cohen, MD, Alexander S. Gallus, MD, Giancarlo Agnelli, MD, Harry R Buller, MD PhD, Raphael Pak, PhD, Anthony R. Porcari, PhD PharmD, Gary E. Raskob, PhD, Jeffrey I. Weitz, MDFRCPC, Takaharu Yamabe, PhD
Journal: Blood
Blood (2014) 124 (21): 1543.
https://doi.org/10.1182/blood.V124.21.1543.1543
Published: 2014
Journal Articles

The effect of low-molecular-weight heparin in cancer patients: the mirror image of survival?

Sandro Barni, Erminio Bonizzoni, Melina Verso, Gualberto Gussoni, Fausto Petrelli, Tania Perrone, Giancarlo Agnelli
Journal: Blood
Blood (2014) 124 (1): 155–156.
https://doi.org/10.1182/blood-2014-03-561761
Published: 2014
Journal Articles

Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism

Giancarlo Agnelli, MD, Harry Roger Buller, MD, PhD, Alexander Cohen, MD, Madelyn Curto, DVM, Alexander S. Gallus, M.D., Margot R. Johnson, MD, BSC, Anthony R. Porcari, PhD, PharmD, Gary E Raskob, PhD, Jeffrey I. Weitz, MD
Journal: Blood
Blood (2012) 120 (21): LBA-1.
https://doi.org/10.1182/blood.V120.21.LBA-1.LBA-1
Published: 2012
Journal Articles

Aspirin After Oral Anticoagulants for Prevention of Recurrence in Patients with Unprovoked Venous Thromboembolism. the Warfasa STUDY

Cecilia Becattini, MD, Giancarlo Agnelli, Renzo Poggio, MD, Sabine Eichinger, MD, Eugenio Bucherini, MD, Mauro Silingardi, MD, Marina Bianchi, MD, Marco Moia, MD, Walter Ageno, MD, Maria Rita Vandelli, MD, Elvira Grandone, MD, Sergio Siragusa, MD, Rosamaria Salvi, MD, Luigi Ria, MD, Nello Zanatta, MD, Daniela Poli, MD, Giuseppe Camporese, MD, Aldo Salvi, MD, Roberto Santi, MD, Claudio Cimminiello, MD, Gianluigi Scannapieco, MD, Giovanni Barillari, MD, Egidio De Gaudenzi, MD, Roberto Cappelli, MD, Giovanni di Minno, MD, Gabriele Frausini, MD, Carlo Bova, MD, Paolo Prandoni
Journal: Blood
Blood (2011) 118 (21): 543.
https://doi.org/10.1182/blood.V118.21.543.543
Published: 2011
Journal Articles

Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO

Daniel George, Giancarlo Agnelli, William Fisher, Ajay Kakkar, Michael R Lassen, Patrick Mismetti, Patrick Mouret, Francesca Lawson, Alexander G.G. Turpie
Journal: Blood
Blood (2011) 118 (21): 206.
https://doi.org/10.1182/blood.V118.21.206.206
Published: 2011
Journal Articles

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

Ajay K. Kakkar, MBBS, PhD, Giancarlo Agnelli, William D. Fisher, MD, Daniel George, Patrick Mouret, Michael R. Lassen, MD, Patrick Mismetti, Judith Murphy, Alexander G.G. Turpie
Journal: Blood
Blood (2010) 116 (21): 188.
https://doi.org/10.1182/blood.V116.21.188.188
Published: 2010
Journal Articles

Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies

Wael Saber, MD, MS, Teng Moua, MD, Eliot C. Williams, MD, PhD, Melina Verso, MD, Giancarlo Agnelli, MD, Stephen Couban, MD, Annie Young, RN, Marcello De Cicco, MD, Roberto Biffi, MD, Cornelis J. van Rooden, MD, Menno V. Huisman, MD, PhD, Daniele Fagnani, MD, Claudio Cimminiello, MD, Marco Moia, MD, Stephen P. Povoski, MD, Sharp Malak, MD, MPH, Agnes Y. Lee, MD, MSc, FRCPC
Journal: Blood
Blood (2008) 112 (11): 3814.
https://doi.org/10.1182/blood.V112.11.3814.3814
Published: 2008
Journal Articles

A Randomized Double-Blind Placebo-Controlled Study on Nadroparin for Prophylaxis of Thromboembolic Events in Cancer Patients Receiving Chemotherapy: The PROTECHT Study

Giancarlo Agnelli, M.D., Gualberto Gussoni, M.D., Carlo Bianchini, M.D., Melina Verso, M.D., Maurizio Tonato, M.D.
Journal: Blood
Blood (2008) 112 (11): 6.
https://doi.org/10.1182/blood.V112.11.6.6
Published: 2008
Journal Articles

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Clinical Trials & Observations
Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, Annelise Segers
Journal: Blood
Blood (2008) 112 (6): 2242–2247.
https://doi.org/10.1182/blood-2008-05-160143
Published: 2008
Includes: Supplemental data
Journal Articles

Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.

Bengt I. Eriksson, MD, PhD, Alexander G.G. Turpie, MD, PhD, Michael R. Lassen, MD, PhD, Martin H. Prins, MD, PhD, Giancarlo Agnelli, MD, PhD, Peter Kälebo, MD, PhD, Graham Wetherill, MSc, Lambertus Meems, MSc.
Journal: Blood
Blood (2007) 110 (11): 309.
https://doi.org/10.1182/blood.V110.11.309.309
Published: 2007
Journal Articles

Rivaroxaban Has Predictable Pharmacokinetics (PK) and Pharmacodynamics (PD) When Given Once or Twice Daily for the Treatment of Acute, Proximal Deep Vein Thrombosis (DVT).

Wolfgang Mueck, PhD, Giancarlo Agnelli, MD, Harry Buller, MD
Journal: Blood
Blood (2007) 110 (11): 1880.
https://doi.org/10.1182/blood.V110.11.1880.1880
Published: 2007